Literature DB >> 11254755

Nutritional lipid emulsions modulate cellular signaling and activation of human neutrophils.

G Wanten1, S van Emst-De Vries, T Naber, P Willems.   

Abstract

Although numerous studies suggest that nutritional lipids modulate human immune responses, the mechanism behind this observation remains unclear. On the basis of the hypothesis that lipids might affect cellular signaling we evaluated the effects of various lipid emulsions on two major pathways involved in neutrophil activation: second messenger (Ca(2)+) mobilization and protein kinase C (PKC) activation. Activation by opsonized yeast particles (serum-treated zymosan; STZ) increased cytosolic [Ca(2)+] ([Ca(2)+](i)) in neutrophils, with an initial slow rise that turned into a fast phase until a plateau was reached. The PKC activator 4-alpha-phorbol 12-myristate 13-acetate (PMA) markedly increased the initial STZ-induced [Ca(2)+](i) rise. This PMA effect was mimicked by emulsions containing medium-chain triglycerides (MT), but not by long-chain triglycerides (LT) or structured lipids (SL). However, like PMA, all emulsions decreased the STZ-induced [Ca(2)+](i) plateau and all activated purified PKC, suggesting that only MT emulsions activate PKC in the context of the intact cell. MT, like PMA, evoked a leftward shift of the dose-response curve for the STZ-induced [Ca(2)+](i) rise, indicating PKC-dependent sensitization of neutrophils for stimulation by STZ. This study is the first to show that nutritional lipids distinctively modulate cellular signaling and stimulation of neutrophils through effects on calcium mobilization and PKC activation: i) MT emulsions sensitize neutrophils for STZ in a PKC-dependent manner, and ii) MT, LT, and SL emulsions all reduce the stimulatory effect of STZ in a nonspecific manner. -- Wanten, G., S. van Emst-de Vries, T. Naber, and P. Willems. Nutritional lipid emulsions modulate cellular signaling and activation of human neutrophils. J. Lipid Res. 2001. 42: 428--436.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254755

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  7 in total

Review 1.  Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis.

Authors:  Antonie J H H M van Oostrom; Jeroen van Wijk; Manuel Castro Cabezas
Journal:  Drugs       Date:  2004       Impact factor: 9.546

2.  Signaling mechanisms of enhanced neutrophil phagocytosis and chemotaxis by the polysaccharide purified from Ganoderma lucidum.

Authors:  Ming-Jen Hsu; Shiuh-Sheng Lee; Sho Tone Lee; Wan-Wan Lin
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

3.  Understanding postprandial inflammation and its relationship to lifestyle behaviour and metabolic diseases.

Authors:  Boudewijn Klop; Spencer D Proctor; John C Mamo; Kathleen M Botham; Manuel Castro Cabezas
Journal:  Int J Vasc Med       Date:  2011-09-25

4.  The effects of long-term total parenteral nutrition on gut mucosal immunity in children with short bowel syndrome: a systematic review.

Authors:  Beyhan Duran
Journal:  BMC Nurs       Date:  2005-02-01

5.  Patients with insulin-dependent diabetes or coronary heart disease following rehabilitation express serum fractalkine levels similar to those in healthy control subjects.

Authors:  Lars Maegdefessel; Axel Schlitt; Susanna Pippig; Bernhard Schwaab; Kerstin Fingscheidt; Uwe Raaz; Michael Buerke; Harald Loppnow
Journal:  Vasc Health Risk Manag       Date:  2009-10-12

6.  Unsaturated long-chain fatty acids induce the respiratory burst of human neutrophils and monocytes in whole blood.

Authors:  Björn Jüttner; Janina Kröplin; Sina M Coldewey; Lars Witt; Wilhelm A Osthaus; Christian Weilbach; Dirk Scheinichen
Journal:  Nutr Metab (Lond)       Date:  2008-07-14       Impact factor: 4.169

7.  Tocopherol and tocotrienol homologs in parenteral lipid emulsions.

Authors:  Zhidong Xu; Kevin A Harvey; Thomas M Pavlina; Gary P Zaloga; Rafat A Siddiqui
Journal:  Eur J Lipid Sci Technol       Date:  2014-08-28       Impact factor: 2.679

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.